Clinical Trials on Hereditary Breast and Ovarian Cancer in Ireland
Total 1357 results
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOsteoporosis | Ovarian Carcinoma | Hereditary Breast and Ovarian Cancer SyndromeUnited States
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
National Human Genome Research Institute (NHGRI)CompletedMelanoma | Breast Neoplasm | Ovarian Neoplasm | Hereditary Neoplastic SyndromeUnited States, Finland, Iceland, Sweden
-
Novartis PharmaceuticalsCompletedHR+/HER2- Advanced or Metastatic Breast CancerIreland
-
Cancer Trials IrelandRecruitingPrimary Breast Cancer | Recurrent/Metastatic Breast CancerIreland
-
Cancer Trials IrelandTerminatedHER2-positive Breast Cancer | TNM Stage II-IV Breast CancerIreland, Italy
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States, Colombia, Mexico, Chile
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
National Health Service, United KingdomSouthern Health and Social Care TrustCompleted
-
Cancer Trials IrelandCompletedBreast Cancer | HER2 Positive Breast Cancer | HER2 Negative Breast CancerIreland
-
Beaumont HospitalCompleted
-
Cancer Trials IrelandTerminated
-
Cancer Trials IrelandCompleted
-
MVG Industries SASRecruitingBreast CancerIreland
-
Women and Infants Hospital of Rhode IslandTerminatedBreast Cancer | Ovarian CancerUnited States
-
MVG Industries SASHRB Clinical Research Facility, Galway (CRFG)CompletedBreast Cancer | Breast CystIreland
-
Cancer Trials IrelandCompletedBreast CancerIreland
-
Pro-Change Behavior SystemsRecruitingMental Health Issue | Hereditary CancerUnited States
-
Cancer Trials IrelandTerminated
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United Kingdom, Korea, Republic of, Australia, United States, Spain
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
University College CorkCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Nausea and Vomiting | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Stage IIA Fallopian Tube Cancer | Stage... and other conditionsUnited States
-
Cancer Trials IrelandTerminated
-
Syndax PharmaceuticalsCompleted
-
Paul Speiser, Prof.MD,CompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Czechia, Germany, Ireland
-
Cancer Trials IrelandCompletedMetastatic Breast CancerIreland
-
University of Dublin, Trinity CollegeUnknownCancer, Breast | Malignancy | Cancer, ColorectalIreland
-
Cancer Trials IrelandCompletedHER2 Positive Breast CancerIreland
-
Cork University HospitalUnknown
-
University of NebraskaNational Cancer Institute (NCI)CompletedStage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States
-
Sidekick HealthLandspitali University Hospital; Ljósið Cancer Rehabilitation CenterActive, not recruiting
-
Cancer Research UKTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited Kingdom
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditionsUnited States
-
Cancer Trials IrelandCompleted
-
Medical University of ViennaCompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Belgium, Czechia, Denmark, Germany, Ireland, Netherlands, United Kingdom
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
Mater Misericordiae University HospitalCompletedQuality of Life | Breast Cancer | Chronic Pain | Chronic Postsurgical PainIreland
-
Dublin City UniversityRoyal College of Surgeons, Ireland; Mater Misericordiae University HospitalActive, not recruitingOvarian Cancer | Colon Cancer | Appendix Cancer | Rectum Cancer | Peritoneal MalignancyIreland
-
PfizerCompleted
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
BicycleTx LimitedRecruitingHead and Neck Cancer | Ovarian Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced Solid Tumor Historically Known for High EphA2 Expression | Urothelial Cancer | Gastric/Upper Gastrointestinal CancerUnited States, Belgium, Korea, Republic of, Spain, United Kingdom
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
Women and Infants Hospital of Rhode IslandAmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Syros PharmaceuticalsTerminatedBreast Cancer | Ovarian Cancer | Advanced Solid TumorsUnited States, Canada, France
-
Women and Infants Hospital of Rhode IslandOrtho Biotech, Inc.Terminated
-
Dana-Farber Cancer InstituteNanoString Technologies, Inc.Active, not recruiting
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedBreast Carcinoma | Fallopian Tube Carcinoma | Ovarian Neoplasm | Primary Peritoneal CarcinomaUnited States